Navigation Links
Penn Treaty Files 2006 Form 10-K
Date:4/2/2008

ALLENTOWN, Pa., April 2, 2008 /PRNewswire-FirstCall/ -- Penn Treaty American Corporation (NYSE: PTA) today announced that it has filed its Form 10-K and audited financial results for the period ended December 31, 2006, reporting a net loss of $33.2 million, or $1.42 per fully diluted share. Book value at December 31, 2006 was $8.91 per fully diluted share.

Penn Treaty filed its unaudited financial statements and related disclosures for the period ended December 31, 2006 on Form 8-K on February 1, 2008. The Company has since performed an additional evaluation of its claims reserves and determined to increase reserves by $9.6 million at December 31, 2006, which decreased book value per share by $.24 from its previously announced results.

The filing of its Form 10-K and audited financial results satisfies the requirements of the New York Stock Exchange ("NYSE") for continued trading of the Company's common stock. The NYSE had granted the Company an extension on trading through April 2, 2008.

The Company will host a conference call for investors on Tuesday, April 15, 2008 at 2 pm EDT. At that time, the Company will provide an operational update for the first quarter of 2008. The Company is focusing its efforts on the audit of its 2007 statutory and GAAP financial statements and will provide an update on the progress of these audits on the conference call. Investors and analysts may participate on the conference call by dialing 800.762.6568. The call will be available for replay by calling 800.475.6701, access code 918239. The call will also be available on the Company's website, http://www.penntreaty.com, beginning Thursday, April 17, 2008.

The Company, through i
'/>"/>

SOURCE Penn Treaty American Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Penn Treaty Introduces LTCi QuickPass(SM) Program
2. Nations to Launch Negotiations on Treaty to Combat Illicit Tobacco Trade
3. U.S. on Sidelines as Nations Launch Negotiations on Treaty to Combat Smuggling, Counterfeiting and Other Illicit Trade in Tobacco Products
4. Penn Treaty Urges Americans To Plan for Their Future During Long-Term Care Awareness Week
5. Penn Treaty First To Offer Brain Fitness Program
6. Retail Industry Leaders Association Files Amicus in California Health Care Litigation
7. Conseco Files 10-K and Sets Earnings Release Date
8. Sunrise Files 2006 Form 10-K
9. Quixtar Files Suit Against MonaVie To Protect Consumers, Halt Unfair Competition
10. Parker Waichman Alonso LLP Files Suit Against General Electric Company on Behalf of a Man Who Developed Nephrogenic Systemic Fibrosis (NSF) from Contrast Agent Omniscan
11. Watson Files Application for Generic SEASONIQUE(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2008)...srupt normal development, mouse study finds , ... few glasses of wine over a short period in early ...chers from the Medical College of Georgia. , T...affects one in 1,000 babies, include facial malfor...ye openings, and a short nose. Researchers are inv...
(Date:8/29/2008)...-FirstCall/ -- Landauer, Inc. (NYSE:,LDR) announce...ular,quarterly cash dividend of $0.50 per share fo...will be paid on October 3, 2008, to shareholders o... Landauer is the leading provider of analytical se... radiation exposure. For more than 50 years,the C...
(Date:8/29/2008)...Telemedicine Encounter Management Systems (TEMS) t... possible solution to national health care problem...WEB) August 29, 2008 -- If there has been any one ...Democratic National Convention it has been the par...lth care issues., , ,Our Democratic leadership rec...
(Date:8/28/2008)...ia led to daytime tiredness, symptoms of depressio... -- Older adults who live with and provide direct ...ve significantly worse sleep than other older adul... 31 caregivers and 102 noncaregivers, ages 60 to 8...t than non-caregivers and took about 10 minutes lo...
Breaking Medicine News(10 mins):Health News:Alcohol in Early Pregnancy May Prompt Fetal Cell Death 2Health News:AMD Global Telemedicine Inc. Invited to Attend Democratic National Convention 2Health News:Older Caregivers Prone to Worse Sleep Patterns 2
...iling in their MBBS examinations in Rajasthan need...ical University// is conducting MBBS examinations ...g questioned by many. These examinations are bei...g number of failures in MBBS and to help those stu...
...ng vacated by the National Enquirer after an anthr...fe, more than two years// after cleanup began, acc... editor for American Media Inc., died in October 2...rax in an envelope mailed to the building, which h...
...n health officials have doomsday predictions for t...es are taken// to curb HIV/AIDS infection. Accor... of Malaysia, the country will have a head count o... by 2015. Of a population of 30 million, 73 thous...
...ers of the international Horse Genome Sequencing P... the horse genome// sequence has been completed an...d veterinary researchers around the globe. The fi...ists with a new set of tools for investigating equ...
Other Medicine News:
(Date:8/27/2008)... Memorial Hospital one of 18 centers involved in 1...wire/ -- Results of a 10-year study,published in t...edicine,found that magnesium sulfate administered ...educed the risk of cerebral palsy by 50 percent. T...te (BEAM) trial was,conducted in 18 centers in the...
(Date:8/27/2008)...Phase 3 data, from BLISS-52 trial, expected by mid...6, expected by fall 2009 -, ROCKVILLE, Md., Aug. ..., Inc. (Nasdaq: HGSI ) today announced it has com...the second of two pivotal Phase 3,randomized clini...nts with,active systemic lupus erythematosus (SLE)...
(Date:8/26/2008)...ds most patients can drive safely six weeks follow...PRNewswire-USNewswire/ -- Six weeks following,buni...that they are able to,get back behind the wheel of... issue of The Journal of Bone and Joint Surgery ( ...rake time response in patients who underwent a,fir...
(Date:8/26/2008)...Aug. 26 /- Omeros Corporation today a...se 1/Phase 2 trial investigating,OMS103HP in arthr...ction,surgery. OMS103HP is an investigational drug...solution and is designed to improve postoperative,...n and allow patients an,earlier return to work. Th...
Breaking Medicine Technology:National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births 2National Study Shows Magnesium Sulfate Reduces Risk of Cerebral Palsy in Premature Births 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 2Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 3Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 4Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 5Human Genome Sciences Completes Enrollment in Second Phase 3 LymphoStat-B(R) Trial 6Braking After Bunion Surgery 2Braking After Bunion Surgery 3Omeros Announces Publication of Clinical Results for OMS103HP in Arthroscopy: The Journal of Arthroscopic and Related Surgery 2Love and Diabetes 3A dLife Valentines Day Quiz Tests and Teaches Important Relationship Lessons for People With Diabetes 11380 1Love and Diabetes 3A dLife Valentines Day Quiz Tests and Teaches Important Relationship Lessons for People With Diabetes 11380 2Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 1Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 2Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 3Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 4Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 5Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 6Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 7Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 8Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 9Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 10Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 11Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 12Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 13Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 14Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 15Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 16Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 17Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 18Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 19Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 20Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 21Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 22Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 23Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 24Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 25Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 26Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 27Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 28Beckman Coulters 4th Quarter and Full Year 2007 Revenue Grows 10 8 25 and 9 2 25 Respectively 3B 2007 Earnings Per Share Beat Outlook 11375 29e Smart 28R 29 Technologies Delivers Its New Super Smart Card 28TM 29 in South Korea 2161 1e Smart 28R 29 Technologies Delivers Its New Super Smart Card 28TM 29 in South Korea 2161 2American Heart Association Themed Issue Journal Report 3A Journal Edition Dedicated to Womens Unique Hypertension Issues 11371 1American Heart Association Themed Issue Journal Report 3A Journal Edition Dedicated to Womens Unique Hypertension Issues 11371 2American Heart Association Themed Issue Journal Report 3A Journal Edition Dedicated to Womens Unique Hypertension Issues 11371 3American Heart Association Themed Issue Journal Report 3A Journal Edition Dedicated to Womens Unique Hypertension Issues 11371 4American Heart Association Themed Issue Journal Report 3A Journal Edition Dedicated to Womens Unique Hypertension Issues 11371 5
...r 27, 2007 - Inotek,Pharmaceuticals Corporation an... clinical data demonstrating the safety of INO-100...ntative agent for,cardiac reperfusion injury. The ...ated myocardial infarction (STEMI) undergoing,prim...tation was,made in a poster session at the America...
...ew study shows that as rates,of diabetes have rise...sease (CVD) linked to diabetes has also,increased.... efforts to,prevent diabetes and to aggressively t... diabetes, according to the investigators,from the...f the,National Heart, Lung, and Blood Institute (N...
Other Medicine Technology:Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 2Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 3Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 4Increasing Proportion of Cardiovascular Disease Due to Diabetes,Over the Last 50 Years 2Increasing Proportion of Cardiovascular Disease Due to Diabetes,Over the Last 50 Years 3
...or Digital Thermostat and Digital Display. , Exter...inum ends. , Interiorwhite anodized aluminum with...frigeration (134A). , Temperature range 0C to 10C...-place polyurethane high density cell insulation (...
...ratory system for pH and temperature measurements....d when used with a temperature probe (ATC) or a 3-...oint calibration with Auto-Find automatic buffer r...10.01 and 12.45) and Auto-Read for locking onto st...
... Detectors provide unmatched value and flexibility.... Capable of performing fluorescence, luminescence...t, the DTX Series can operate as standalone instru... Coulters Biomek Laboratory Automation Workstation...
...hput Screening (HTS), Analyst HT smoothes the tran...on modalities and assay performance of Analyst AD,..., time-resolved fluorescence, luminescence, absorb...otic environments, including those from Beckman Co...
Medicine Products: